Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
very engaged, close to the employees
Qual è la parte migliore del tuo compenso?
annual bonus is fairly distributed
Quali sono alcune delle cose migliori della tuo team?
team members are knowledgeable and we help each other
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
the thinking and all the activities are for the patients
Che cosa ti rende più felice sul posto di lavoro?
I have got the opportunity to be involved in the development of the drug until market approval
Other Employee Reviews for Karyopharm Therapeutics
×